1. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy

   • Constantin N. Baxevanis
   • Sonia A. Perez
   • Michael Papamichail

   Review 15 August 2008 Pages: 317 - 324

2. Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients

   • Ashley J. Knights
   • Natko Nuber
   • Alfred Zippelius

   Original Article 29 July 2008 Pages: 325 - 338

   

3. Chordoma and chondrosarcoma gene profile: implications for immunotherapy

   • Joseph H. Schwab
   • Patrick J. Boland
   • Cristina R. Antonescu

   Original Article 19 July 2008 Pages: 339 - 349

   

4. Generation of a human IgM monoclonal antibody directed against HLA class II molecules: a potential agent in the treatment of haematological malignancies

   • Belén Díaz
   • Irene Sanjuan
   • África González–Fernández

   Original Article 02 August 2008 Pages: 351 - 360

   

5. TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis

   • Roghieh Djafarzadeh
   • Valeria Milani
   • Peter J. Nelson

   Original Article 11 July 2008 Pages: 361 - 371

   

6. A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy

   • Caroline Schroten-Loef
   • Corrina M. A. de Ridder
   • Robert Kraaij

   Original Article Open access 19 July 2008 Pages: 373 - 381

   

7. Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

   • Jennifer A. Wargo
   • Paul F. Robbins
   • Richard A. Morgan

   Original Article 02 August 2008 Pages: 383 - 394

   

8. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β₂-microglobulin genes

   • Chin-Hsuan Hsieh
   • Ya-Jan Hsu
   • Shuen-Kuei Liao

   Original Article 15 August 2008 Pages: 395 - 408

   

9. cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor {alpha}2 chain

   • Wenqiao Yu
   • Zhipeng Su
   • Yanjun Zeng

   Original Article 02 August 2008 Pages: 409 - 413

   

10. Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies

    • Allison S. Drake
    • Michael T. Brady
    • Meir Wetzler

    Original Article 02 August 2008 Pages: 415 - 427

    

11. Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis

    • Ingrid M. Overes
    • T. Henriëtte Levenga
    • Harry Dolstra

    Original Article Open access 22 August 2008 Pages: 429 - 439

    

12. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer

    • Masahiro Ohara
    • Yoshiyuki Yamaguchi
    • Morihito Okada

    Original Article Open access 07 August 2008 Pages: 441 - 447

    

13. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer

    • Ninke Leffers
    • Marloes J. M. Gooden
    • Hans W. Nijman

    Original Article Open access 13 September 2008 Pages: 449 - 459

    

14. Potential immunologic effects of statins in cancer following transplantation

    • J. E. Fildes
    • S. M. Shaw
    • N. Yonan

    Short Communication 04 June 2008 Pages: 461 - 467

    

15. p27 and salivary cancer

    • Ofer Ben-Izhak
    • Sharon Akrish
    • Rafael M. Nagler

    Short Communication 29 July 2008 Pages: 469 - 473